Literature DB >> 2888816

Use of teicoplanin for Hickman catheter associated staphylococcal infection in immunosuppressed patients.

A Webster1, S J Russell, R L Souhami, J D Richards, A H Goldstone, R N Grüneberg.   

Abstract

Antibiotic-resistant coagulase-negative staphylococci are a frequent cause of infection in indwelling central venous (Hickman) catheters. Teicoplanin has been evaluated in the treatment of 19 immunosuppressed patients with staphylococcal Hickman catheter infections, nine of whom were septicaemic. All infections were eradicated, with minimal side effects. In 16 cases, the catheter was retained until no longer required. Two recurrent infections were eradicated by a second course of teicoplanin. We conclude that teicoplanin is an effective and well-tolerated antibiotic in the treatment of Hickman catheter infections in immunosuppressed patients.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2888816     DOI： 10.1016/0195-6701(87)90036-3

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


  6 in total

Review 1.  A survey of the use of teicoplanin in patients with haematological malignancies and solid tumours.

Authors:  J M Davies
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

Review 2.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 3.  Teicoplanin: 10 years of clinical experience.

Authors:  M Trautmann; H Wiedeck; M Ruhnke; M Oethinger; R Marre
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

4.  Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.

Authors:  P Van der Auwera; M Aoun; F Meunier
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

5.  Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters.

Authors:  S R Smith; J Cheesbrough; R Spearing; J M Davies
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

6.  Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides.

Authors:  A A Fauser; E Lang; G Dölken; K J Bross; J Schmid; F Sörgel
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.